Manuel López-Rivadulla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Manuel López-Rivadulla has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Angelines Cruz
Toxicology Service, Institute of Forensic Sciences, Universidade de Santiago de Compostela, Rúa San Francisco, s/n, 15782 Santiago de Compostela, Spain
13 shared publications - Elena Lendoiro
University of Santiago de Compostela
7 shared publications - Ana de Castro
Toxicology Service, Institute of Forensic Sciences, University of Santiago de Compostela, San Francisco, s/n, Santiago de Compostela 15782, Spain
6 shared publications A.M. Bermejo
Institute of Legal Medicine, Service of Forensic Toxicology, Faculty of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
5 shared publicationsA. Cruz
Forensic Toxicology service , Legal Medicine Institute. Faculty of Medicine. University of Santiago de Compostela , Spain
4 shared publicationsL. Concheiro
Institute of Legal Medicine, Service of Forensic Toxicology, Faculty of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
4 shared publications
Latest Publications
- 1 January 2022
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 208, 114443
Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination
- 1 January 2022
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 208, 114443
Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination
- Open Access
- 1 September 2021
- Published by Elsevier in Forensic Science International
- Vol. 326, 110935
Determination of antidepressants and benzodiazepines in paired hair and nail samples
- 1 September 2021
- Published by Elsevier in Forensic Science International
- Vol. 326, 110935
Open AccessDetermination of antidepressants and benzodiazepines in paired hair and nail samples
- 22 August 2018
- Published by Springer Nature in Forensic Toxicology
- Vol. 37 (1) , 90-103
Detection of in utero ethanol exposure via ethyl glucuronide and ethyl sulfate analysis in umbilical cord and placenta
- 22 August 2018
- Published by Springer Nature in Forensic Toxicology
- Vol. 37 (1) , 90-103
Detection of in utero ethanol exposure via ethyl glucuronide and ethyl sulfate analysis in umbilical cord and placenta
- Open Access
- 1 May 2018
- Published by Elsevier in Forensic Science International
- Vol. 286, 239-244
Usefulness of hair analysis and psychological tests for identification of alcohol and drugs of abuse consumption in driving license regranting
- 1 May 2018
- Published by Elsevier in Forensic Science International
- Vol. 286, 239-244
Open AccessUsefulness of hair analysis and psychological tests for identification of alcohol and drugs of abuse consumption in driving license regranting
- Open Access
- 25 September 2017
- Published by Wiley in Drug Testing and Analysis
- Vol. 10 (4) , 636-643
Detection of in utero cannabis exposure by umbilical cord analysis
According to the 2014 National Survey on Drug Use and Health, 5.3% of pregnant women smoked marijuana in the past month. This prevalence is expected to increase as a growing number of states and countries are now considering legalization. Although the umbilical cord is becoming a useful objective tool to detect in utero drug exposure, currently data about analytical methods and its utility to detect cannabis exposure are scarce. The objective of this work was to develop a method for the determination of Δ9‐tetrahydrocannabinol (THC), 11‐hydroxyTHC (THC‐OH), 11‐nor‐9‐carboxy‐THC (THCCOOH), 8‐β‐11‐dihydroxyTHC (THC‐diOH), THC and THCCOOH glucuronides, and cannabidiol (CBD) in the umbilical cord by liquid chromatography–tandem mass spectrometry (LC–MS/MS) with dual ionization source. Umbilical cord samples (0.5 g) were homogenized in methanol and extracted by solid‐phase extraction. Reversed‐phase chromatographic separation was performed in 14 minutes, and 2 transitions per analyte were monitored in multiple reaction monitoring mode. Method validation included linearity (1–10 to 20–200 ng/g), precision (4.1%–23.4%), accuracy (87.5%–111.4%), matrix effect (‐54.8% to ‐5.8%), extraction efficiency (25%–45.6%), limits of detection and quantification (1–10 ng/g), and endogenous (n = 5) or exogenous interferences (not detected). The method was applied to 13 authentic samples from cannabis‐exposed newborns, which meconium samples had tested positive for cannabis. Twelve cord specimens tested positive for THCCOOH‐glucuronide (1.6–19.1 ng/g). We developed and validated a specific and sensitive method for the simultaneous determination of THC, its metabolites, including THC and THCCOOH glucuronides, and CBD in umbilical cord samples by LC–MS/MS. The analysis of authentic samples showed the usefulness of umbilical cord to detect cannabis in utero exposure.
- 25 September 2017
- Published by Wiley in Drug Testing and Analysis
- Vol. 10 (4) , 636-643
Open AccessDetection of in utero cannabis exposure by umbilical cord analysis
According to the 2014 National Survey on Drug Use and Health, 5.3% of pregnant women smoked marijuana in the past month. This prevalence is expected to increase as a growing number of states and countries are now considering legalization. Although the umbilical cord is becoming a useful objective tool to detect in utero drug exposure, currently data about analytical methods and its utility to detect cannabis exposure are scarce. The objective of this work was to develop a method for the determination of Δ9‐tetrahydrocannabinol (THC), 11‐hydroxyTHC (THC‐OH), 11‐nor‐9‐carboxy‐THC (THCCOOH), 8‐β‐11‐dihydroxyTHC (THC‐diOH), THC and THCCOOH glucuronides, and cannabidiol (CBD) in the umbilical cord by liquid chromatography–tandem mass spectrometry (LC–MS/MS) with dual ionization source. Umbilical cord samples (0.5 g) were homogenized in methanol and extracted by solid‐phase extraction. Reversed‐phase chromatographic separation was performed in 14 minutes, and 2 transitions per analyte were monitored in multiple reaction monitoring mode. Method validation included linearity (1–10 to 20–200 ng/g), precision (4.1%–23.4%), accuracy (87.5%–111.4%), matrix effect (‐54.8% to ‐5.8%), extraction efficiency (25%–45.6%), limits of detection and quantification (1–10 ng/g), and endogenous (n = 5) or exogenous interferences (not detected). The method was applied to 13 authentic samples from cannabis‐exposed newborns, which meconium samples had tested positive for cannabis. Twelve cord specimens tested positive for THCCOOH‐glucuronide (1.6–19.1 ng/g). We developed and validated a specific and sensitive method for the simultaneous determination of THC, its metabolites, including THC and THCCOOH glucuronides, and CBD in umbilical cord samples by LC–MS/MS. The analysis of authentic samples showed the usefulness of umbilical cord to detect cannabis in utero exposure.
- 3 October 2016
- Published by Wiley in Drug Testing and Analysis
- Vol. 9 (6) , 898-904
Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy
Drug exposure during pregnancy constitutes a major legal issue and a public health concern. Drug and metabolite determination in biological matrices from mother and newborn is an objective indication of prenatal drug exposure. However, limited data are available regarding the interpretation of these analytical results in terms of window of detection and degree of exposure. We collected paired maternal hair, meconium, placenta, and umbilical cord from 727 mother‐newborn dyads. We analyzed these specimens by liquid chromatography‐tandem mass spectrometry for the determination of cocaine, opioids, methadone, and amphetamines, and compared the analytical results from the four different matrices. The cases were divided in non‐exposure, low, and frequent exposure, based on maternal hair concentrations and segmental analysis by trimesters. For cocaine, 62 cases tested positive in hair, 9 in meconium, 6 in placenta and 7 in umbilical cord. In the case of opioids, 14 maternal hair cases were positive, 11 meconium and umbilical cord and 9 placenta samples. For methadone, 11 cases were positive in hair, 9 in meconium and 6 in placenta and umbilical cord. For amphetamines, 18 cases were positive according to maternal hair, but all meconium, placenta, and umbilical cord tested negative. Maternal hair was the most sensitive specimen to detect drug exposure during pregnancy. Meconium, placenta, and umbilical cord tested positive if hair concentrations showed frequent drug use during the whole pregnancy, especially during the third trimester. Meconium, placenta, and umbilical cord also tested positive for morphine and metabolites, if this drug was administered during labour and delivery. Copyright © 2016 John Wiley & Sons, Ltd.
- 3 October 2016
- Published by Wiley in Drug Testing and Analysis
- Vol. 9 (6) , 898-904
Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy
Drug exposure during pregnancy constitutes a major legal issue and a public health concern. Drug and metabolite determination in biological matrices from mother and newborn is an objective indication of prenatal drug exposure. However, limited data are available regarding the interpretation of these analytical results in terms of window of detection and degree of exposure. We collected paired maternal hair, meconium, placenta, and umbilical cord from 727 mother‐newborn dyads. We analyzed these specimens by liquid chromatography‐tandem mass spectrometry for the determination of cocaine, opioids, methadone, and amphetamines, and compared the analytical results from the four different matrices. The cases were divided in non‐exposure, low, and frequent exposure, based on maternal hair concentrations and segmental analysis by trimesters. For cocaine, 62 cases tested positive in hair, 9 in meconium, 6 in placenta and 7 in umbilical cord. In the case of opioids, 14 maternal hair cases were positive, 11 meconium and umbilical cord and 9 placenta samples. For methadone, 11 cases were positive in hair, 9 in meconium and 6 in placenta and umbilical cord. For amphetamines, 18 cases were positive according to maternal hair, but all meconium, placenta, and umbilical cord tested negative. Maternal hair was the most sensitive specimen to detect drug exposure during pregnancy. Meconium, placenta, and umbilical cord tested positive if hair concentrations showed frequent drug use during the whole pregnancy, especially during the third trimester. Meconium, placenta, and umbilical cord also tested positive for morphine and metabolites, if this drug was administered during labour and delivery. Copyright © 2016 John Wiley & Sons, Ltd.
- 1 January 2016
- Published by Elsevier in Journal of Chromatography A
- Vol. 1429, 53-64
Water-compatible imprinted pills for sensitive determination of cannabinoids in urine and oral fluid
- 1 January 2016
- Published by Elsevier in Journal of Chromatography A
- Vol. 1429, 53-64
Water-compatible imprinted pills for sensitive determination of cannabinoids in urine and oral fluid
- 1 January 2016
- Published by IMR Press in Revista De Neurologia
- Vol. 62 (01) , 48
El monóxido de carbono y la neurología. Réplica
- 1 January 2016
- Published by IMR Press in Revista De Neurologia
- Vol. 62 (01) , 48
El monóxido de carbono y la neurología. Réplica
- 1 January 2015
- Published by IMR Press in Revista De Neurologia
- Vol. 61 (04) , 153
Síndrome neurológico tardío tras intoxicación por monóxido de carbono
- 1 January 2015
- Published by IMR Press in Revista De Neurologia
- Vol. 61 (04) , 153
Síndrome neurológico tardío tras intoxicación por monóxido de carbono
- Open Access
- 1 April 2009
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 33 (3) , 155-161
Ethylglucuronide Determination in Urine and Hair from Alcohol Withdrawal Patients
Two methods for the determination of ethylglucuronide (EtG) in urine and in hair have been developed by liquid chromatography-tandem mass spectrometry. These two methods were fully validated, including linearity (0.25–100 µg/mL in urine; 0.05–5 ng/mg in hair; r2 > 0.99, n = 5), limits of detection (0.1 µg/mL in urine, 0.025 ng/mg in hair) and quantitation (lowest level of the calibration curve), extraction efficiency (> 55%), within-day and between-day imprecision and bias (CV and mean relative error < 15%), matrix effect, and relative ion intensity. These methods have been applied to 541 urine samples and 17 hair specimens collected from 156 alcohol withdrawal patients. The determination of ethanol versus EtG in urine was compared, and also the convenience of EtG determination in hair. EtG in urine and in hair proved to be a powerful tool for monitoring abstinence in these patients.
- 1 April 2009
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 33 (3) , 155-161
Open AccessEthylglucuronide Determination in Urine and Hair from Alcohol Withdrawal Patients
Two methods for the determination of ethylglucuronide (EtG) in urine and in hair have been developed by liquid chromatography-tandem mass spectrometry. These two methods were fully validated, including linearity (0.25–100 µg/mL in urine; 0.05–5 ng/mg in hair; r2 > 0.99, n = 5), limits of detection (0.1 µg/mL in urine, 0.025 ng/mg in hair) and quantitation (lowest level of the calibration curve), extraction efficiency (> 55%), within-day and between-day imprecision and bias (CV and mean relative error < 15%), matrix effect, and relative ion intensity. These methods have been applied to 541 urine samples and 17 hair specimens collected from 156 alcohol withdrawal patients. The determination of ethanol versus EtG in urine was compared, and also the convenience of EtG determination in hair. EtG in urine and in hair proved to be a powerful tool for monitoring abstinence in these patients.